Clinical Trial Update: Improving Medication Safety for Kidney Disease With a Digital Drug Dosing Tool in Nova Scotia Community Pharmacy Practice.

View source ↗

Summary

A clinical trial is evaluating a digital drug dosing tool to improve medication safety for patients with chronic kidney disease stage 4 or 5 in Nova Scotia comm…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease
• Chronic Kidney Disease Stage

Snippet

Sponsor: Nova Scotia Health Authority | Conditions: Chronic Kidney Disease Stage 4, Chronic Kidney Disease Stage 5 | Status: NOT_YET_RECRUITING